About Us  |  Contact Us  |  Español
Butler Hospital
Butler Hospital

Results of Clinical Trials of TMS

The TMS machine used at Butler Hospital was determined by the FDA to provide safe and well-tolerated treatment. The data collected in clinical trials with this device resulted in FDA clearance “for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode.

In an “open label” trial, which is most like a real world clinical practice, approximately 1 out of 2 patients treated with the TMS Therapy device used at Butler Hospital experienced significant improvement in depression symptoms. TMS-treated patients also experienced significant improvement in anxiety, appetite changes, aches and pains, and lack of energy associated with depression.

Approximately 1 out of 3 patients treated with TMS Therapy experienced complete symptom relief at the end of six weeks.

Back to Transcranial Magnetic Stimulation (TMS)

Health Headlines
New Treatment Approved for Rare Form of HemophiliaView in a lightbox
Experts Predict 'Catastrophic' Ebola Epidemic in West Africa if Aid DelayedView in a lightbox
Few U.S. Hospitals Ready to Handle Ebola, Survey FindsView in a lightbox
New York City Ebola Patient in Stable ConditionView in a lightbox
Nurse Nina Pham Heading Home After Beating EbolaView in a lightbox
Butler Hospital
© 2011 Site Index | Disclaimer | Legal Notices | Talks Your Health